Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent

OBJECTIVES: To analyse the effect of biological agents (BAs) in terms of achieving inactive disease (ID) or clinical remission (CR) in patients with systemic juvenile idiopathic arthritis (SJIA), to describe effects of switching or discontinuing a BA and to assess the proportion of patients able to...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:RMD Open
Hlavní autoři: Woerner, A, Uettwiller, F, Melki, I, Mouy, R, Wouters, C, Bader-Meunier, B, Quartier, P
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2015
Témata:
Paediatric Rheumatology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4613174/
https://ncbi.nlm.nih.gov/pubmed/26509061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2014-000036
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky